Is GILD a good stock to buy? We came across a bullish thesis on Gilead Sciences, Inc. on r/investing_discussion by Variant_Invest. In this article, we will summarize the bulls’ thesis on GILD. Gilead Sciences, Inc.'s share was trading at $133.73 as of May 26th. GILD’s trailing and forward P/E were 18.19 and 15.22 respectively according to Yahoo Finance.
Pressmaster/Shutterstock.com
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States and internationally. GILD is being mischaracterized by the market as a slow-growth HIV cash cow despite a rapidly shifting pipeline that increasingly skews toward long-acting HIV innovation and a credible oncology expansion, suggesting the current valuation underappreciates its multi-platform earnings durability.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
Pressmaster/Shutterstock.com
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States and internationally. GILD is being mischaracterized by the market as a slow-growth HIV cash cow despite a rapidly shifting pipeline that increasingly skews toward long-acting HIV innovation and a credible oncology expansion, suggesting the current valuation underappreciates its multi-platform earnings durability.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
3 months ago
